Old Web
English
Sign In
Acemap
>
authorDetail
>
D. Bottino
D. Bottino
Pathology
Medicine
Pharmacodynamics
PI3K/mTOR Inhibitor BEZ235
PK/PD models
2
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P1.13-44 Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
2018
Journal of Thoracic Oncology
Joel W. Neal
Robert C. Doebele
G. J. Riely
Alexander I. Spira
Leora Horn
Zofia Piotrowska
Daniel B. Costa
Steven Zhang
D. Bottino
J Zhu
D. Kerstein
Sigui Li
Pasi A. Jänne
Show All
Source
Cite
Save
Citations (16)
Clinical pharmacokinetic-pharmacodynamic (PK/PD) modeling study of the novel dual PI3K/mTOR inhibitor BEZ235.
2011
Journal of Clinical Oncology
D. Bottino
J. Tabernero
H. A. Burris
Carolyn D. Britten
Lisa Chen
Johanna C. Bendell
O. Chiparus
Vincent Duval
E. di Tomaso
C. Sarr
Wolfgang Hackl
J. Baselga
J. Rodon Ahnert
Show All
Source
Cite
Save
Citations (1)
1